Scientists and Researchers have opened another path to tracking origins of family cancer problems. In an effort to assist GP's and physicians complete their work more successfully, genetic investigations are now proving a more common path into why a patient contracts cancer or a tumor.
Much of this research is covered by germline inherited gene mutations, which are passed from parent to child. Risk of disease is greatly increased during lifetime of people who inherit them due to the fact that mutations exist in every cell in the body.
In late 2007, Memorial Sloan-Kettering Cancer Center made a land mark decision to obtain consent of patients to include inherited genetic information in patient medical records. This information would assist a family physician to assess risk of cancer or tumor intrusion into family health.
In their Clinical Genetics Clinic Service, Memorial Sloan now offers testing for more than 50 kinds of genetic variants linked to cancer. Information from these tests assist decisions on treatments for breast, ovary, colon, thyroid, eye, stomach, pancreas and skin, as well as for childhood cancers. Diseased-linked genes such as BRACA1 and 2 are also placed in this investigational path, although known for their damage caused to breast and ovarian cancers since early 90's.
All this research at Memorial Sloan-Kettering enables quick decision turn arounds for GP's and physicians to attend their patients, as well as building up important data on high-risk families with genetic flow-on genes to continue cancer risk. It also provids more clues about what really causes cancer.
Acknowledgement Memorial Sloan-Kettering Cancer Center. Geoff
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment